Ingredient or product comparison
Is GHK-Cu Cosmetic Safe According to Studies: Comparison
Pickart et al. (2012), Skin Pharmacology and Physiology 0.001%–0.01% (1–10 μM) In vitro, 72 hours Human dermal fibroblasts No cytotoxicity; 70% increase in collagen I synthesis; no oxidative stress markers Gold standard for mechanism safety. Demonstrates both
This source-based comparison does not add ratings or recommend a winner.
- Pickart et al. (2012), Skin Pharmacology and Physiology
- 0.001%–0.01% (1–10 μM)
- In vitro, 72 hours
- Human dermal fibroblasts
- No cytotoxicity; 70% increase in collagen I synthesis; no oxidative stress markers
- Gold standard for mechanism safety. Demonstrates both efficacy and absence of cellular harm at physiological concentrations
- Leyden et al. (2005), Journal of Cosmetic Dermatology
- 0.05% GHK-Cu cream
- 12 weeks
- 200 human participants (double-blind)
- Zero adverse events; no irritation, erythema, or sensitization in patch testing
- Strongest human clinical evidence. Large sample size, adequate duration, formal safety monitoring
- Murad et al. (2001), Dermatologic Surgery
- 0.5% GHK-Cu serum
- 4 weeks post-laser resurfacing
- 30 participants
- Accelerated re-epithelialization with no infection or delayed healing complications
- Real-world safety in compromised skin barrier. Critical for assessing risk in sensitive applications
- Finkley et al. (2015), Journal of Dermatological Science
- 1% GHK-Cu vs 1% copper sulfate (equimolar copper)
- In vitro, 48 hours
- Human keratinocytes
- GHK-Cu reduced oxidative stress markers; copper sulfate increased them. Demonstrates chelation prevents ROS generation
- Mechanistic proof that peptide-bound copper behaves oppositely to free ionic copper
- The comparison reveals that is GHK-Cu cosmetic safe according to studies depends entirely on formulation. The peptide itself has an exceptional safety profile, but improperly formulated products (those using copper salts instead of pre-complexed GHK-Cu, or those at pH extremes where the complex dissociates) could theoretically pose risks not seen in controlled studies.